These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 16932553)

  • 1. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage.
    Martin PT
    Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dystroglycanopathies: the new disorders of O-linked glycosylation.
    Martin PT
    Semin Pediatr Neurol; 2005 Sep; 12(3):152-8. PubMed ID: 16584074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Journey into muscular dystrophies caused by abnormal glycosylation.
    Muntoni F
    Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein glycosylation in disease: new insights into the congenital muscular dystrophies.
    Martin-Rendon E; Blake DJ
    Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alpha-dystroglycanopathy (FCMD, MEB, etc): abnormal glycosylation and muscular dystrophy].
    Toda T
    Rinsho Shinkeigaku; 2005 Nov; 45(11):932-4. PubMed ID: 16447766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Fukuyama congenital muscular dystrophy and related alpha-dystroglycanopathies].
    Murakami T; Nishino I
    Brain Nerve; 2008 Oct; 60(10):1159-64. PubMed ID: 18975603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylation defects: a new mechanism for muscular dystrophy?
    Grewal PK; Hewitt JE
    Hum Mol Genet; 2003 Oct; 12 Spec No 2():R259-64. PubMed ID: 12925572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of defective glycosylation in congenital muscular dystrophy.
    Schachter H; Vajsar J; Zhang W
    Glycoconj J; 2004; 20(5):291-300. PubMed ID: 15229394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies.
    Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F
    Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan.
    Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F
    Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
    Endo T
    Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fukutin and alpha-dystroglycanopathies.
    Toda T; Chiyonobu T; Xiong H; Tachikawa M; Kobayashi K; Manya H; Takeda S; Taniguchi M; Kurahashi H; Endo T
    Acta Myol; 2005 Oct; 24(2):60-3. PubMed ID: 16550916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zebrafish models for human FKRP muscular dystrophies.
    Kawahara G; Guyon JR; Nakamura Y; Kunkel LM
    Hum Mol Genet; 2010 Feb; 19(4):623-33. PubMed ID: 19955119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation defects in inherited muscle disease.
    Hewitt JE; Grewal PK
    Cell Mol Life Sci; 2003 Feb; 60(2):251-8. PubMed ID: 12678490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective glycosylation in muscular dystrophy.
    Muntoni F; Brockington M; Blake DJ; Torelli S; Brown SC
    Lancet; 2002 Nov; 360(9343):1419-21. PubMed ID: 12424008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fukuyama-type congenital muscular dystrophy (FCMD) and alpha-dystroglycanopathy.
    Toda T; Kobayashi K; Takeda S; Sasaki J; Kurahashi H; Kano H; Tachikawa M; Wang F; Nagai Y; Taniguchi K; Taniguchi M; Sunada Y; Terashima T; Endo T; Matsumura K
    Congenit Anom (Kyoto); 2003 Jun; 43(2):97-104. PubMed ID: 12893968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscular dystrophies due to defective glycosylation of dystroglycan.
    Muntoni F; Brockington M; Godfrey C; Ackroyd M; Robb S; Manzur A; Kinali M; Mercuri E; Kaluarachchi M; Feng L; Jimenez-Mallebrera C; Clement E; Torelli S; Sewry CA; Brown SC
    Acta Myol; 2007 Dec; 26(3):129-35. PubMed ID: 18646561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosylation defects in muscular dystrophies.
    Haliloğlu G; Topaloğlu H
    Curr Opin Neurol; 2004 Oct; 17(5):521-7. PubMed ID: 15367856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual laminin-binding activity and enhanced dystroglycan glycosylation by LARGE in novel model mice to dystroglycanopathy.
    Kanagawa M; Nishimoto A; Chiyonobu T; Takeda S; Miyagoe-Suzuki Y; Wang F; Fujikake N; Taniguchi M; Lu Z; Tachikawa M; Nagai Y; Tashiro F; Miyazaki J; Tajima Y; Takeda S; Endo T; Kobayashi K; Campbell KP; Toda T
    Hum Mol Genet; 2009 Feb; 18(4):621-31. PubMed ID: 19017726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congenital muscular dystrophy with glycosylation defects of alpha-dystroglycan in Japan.
    Matsumoto H; Hayashi YK; Kim DS; Ogawa M; Murakami T; Noguchi S; Nonaka I; Nakazawa T; Matsuo T; Futagami S; Campbell KP; Nishino I
    Neuromuscul Disord; 2005 May; 15(5):342-8. PubMed ID: 15833426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.